Willis Johnson & Associates, Inc. Bio Path Holdings Inc Transaction History

Willis Johnson & Associates, Inc.

  • $1.31 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 29, 2021
SELL
$3.63 - $11.77 $41,309 - $133,942
-11,380 Closed
0 $0
Q4 2020

Apr 13, 2021
BUY
$3.21 - $5.26 $36,529 - $59,858
11,380 New
11,380 $40,000

About BIO-PATH HOLDINGS INC

BPTH Quotes by TradingView
  • Ticker BPTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 7,160,160
  • Market Cap $5.73M
  • Description
  • Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the...
More about BPTH
Track This Portfolio

Track Willis Johnson & Associates, Inc. Portfolio

Follow Willis Johnson & Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Willis Johnson & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Willis Johnson & Associates, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email